Structures by: Mannava M. K.
Total: 12
Nicorandil-Fumaric acid salt
C8H10N3O4,C4H3O4
CrystEngComm (2020)
a=29.813(6)Å b=4.787(2)Å c=9.861(2)Å
α=90.00(3)° β=90.00(3)° γ=90.00(3)°
Nicorandil-Subaric acid cocrystal
C8H9N3O4,C4H7O2
CrystEngComm (2020)
a=6.835(2)Å b=23.752(5)Å c=8.939(2)Å
α=90° β=101.16(3)° γ=90°
Indapamide-4,4'-Bipyridine cocrystal
C16H16ClN3O3S,C10H8N2
CrystEngComm (2019) 21, 13 2043
a=7.2851(14)Å b=9.0281(17)Å c=38.510(7)Å
α=90° β=95.230(3)° γ=90°
Indapamide-2,2'-Bipyridine cocrystal
C16H16ClN3O3S,C10H8N2
CrystEngComm (2019) 21, 13 2043
a=7.3151(2)Å b=8.9370(3)Å c=38.9526(12)Å
α=90° β=93.702(2)° γ=90°
Indapamide-Phenazine cocrystal
C16H16ClN3O3S,C12H8N2
CrystEngComm (2019) 21, 13 2043
a=7.1759(3)Å b=9.4074(4)Å c=39.0523(17)Å
α=90° β=93.389(2)° γ=90°
Indapamide-1,2-Bis(4-pyridyl)ethylene cocrystal monohydrate
C16H16ClN3O3S,C12H10N2,H2O
CrystEngComm (2019) 21, 13 2043
a=12.2238(2)Å b=14.8267(3)Å c=16.2328(3)Å
α=93.2280(10)° β=107.2640(10)° γ=90.1220(10)°
Indapamide-methylpyridone cocrystal
C16H16ClN3O3S,C6H7NO
CrystEngComm (2019) 21, 13 2043
a=7.765(7)Å b=8.741(8)Å c=34.52(3)Å
α=90° β=93.96(4)° γ=90°
Clotrimazole-2,5-Dihydroxybenzoic acid
C22H18ClN2,C7H5O4
Crystal Growth & Design (2015) 15, 5 2493
a=10.1762(10)Å b=10.6463(8)Å c=13.0417(9)Å
α=108.469(7)° β=102.963(8)° γ=107.069(8)°
Clotrimazole-Caffeic acid-anisole
C23H17ClN2,C9H7O4,C7H8O
Crystal Growth & Design (2015) 15, 5 2493
a=12.4974(17)Å b=14.527(2)Å c=17.789(2)Å
α=90.00° β=96.028(2)° γ=90.00°
Clotrimazole-2,4,6-Trihydroxybenzoic acid
C22H18ClN2,C7H5O5
Crystal Growth & Design (2015) 15, 5 2493
a=12.0214(14)Å b=13.8128(16)Å c=15.9926(18)Å
α=90.00° β=97.934(2)° γ=90.00°
Clotrimazole-Adipic acid
C22H17ClN2,0.5(C6H10O4)
Crystal Growth & Design (2015) 15, 5 2493
a=8.7300(9)Å b=9.6543(9)Å c=13.2542(13)Å
α=74.480(9)° β=84.281(8)° γ=85.466(8)°
Clotrimazole-p-Coumaric acid
C22H18ClN2,C9H7O3
Crystal Growth & Design (2015) 15, 5 2493
a=10.3536(13)Å b=14.9452(14)Å c=16.4976(19)Å
α=90.00° β=90.00° γ=90.00°